See this page online at: http://bioscienceworld.ca/error.lasso
 |
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
“A grand challenge is really a critical barrier between where we are and where we need to be in global health.”
- As quoted by Dr. Peter Singer in the June issue of Biotechnology Focus.
|
Funding supports study of breast cancer gene mutation
A team of Queen’s University researchers receives $450,000 to study a gene mutation common to breast cancer patients.
|
|
Breakthrough heralds era of personalized cancer treatment
Simon Fraser University molecular biologist Stephen Jones is among the researchers leading the charge to deliver personalized therapies tailored to the genetic makeup of individual cancers.
|
|
Miraculins Launches ELISA Kit for Detection of PSP94 in Urine and Announces Distribution Agreement With GenWay Biotech
Miraculins Inc. launches its PSP94 Immunoassay for Urine Specimens, a research use only (RUO) tool utilizing enzyme linked immunosorbent assay (ELISA) for the detection of PSP94 in urine.
|
|
Federal government invest in wind energy in New Brunswick
The Lamèque Wind Power Project, located on the Isle of Lamèque, will receive up to $13.79 million over 10 years through the ecoENERGY for Renewable Power program.
|
|
We Know the What and the Why. Now we need the How.
By Peter Pekos
I don’t expect any readers of this issue to recognize the name of Dr. John Dessauer. His immense contribution to the methods we use for innovation, product development and business management was made a generation ago. |
